Not quite a lot about endocrinology in this, the most influential, medical journal.
first we bumped into a "perspective" article titled "Covid 19 and disparities in nutrition and obesity", a clear proof of human being's capacity to digress and ramble when you haven't got enough data but feel authorized to dictate opinions. The logical process in the article is: Premise 1: Black, latin and native american people (BLN) have more covid cases, hospitalization and deaths that white individuals; Premise 2: BLN have more obesity rates that whites. Conclusion: BLN have more covid because they are fatter. Does it make any sense? Couldn't it be that other socioeconomic conditions, such as overcrowding, difficults to self-isolate etc, explain high infection rates in these populations?
In the section "images" we find a pic of Necrolytic Migratory erythema associated with a glucagonoma. This is a well known finding you can read in every medicine book, but as it's quite unusual you can see the picture. If you were able to live and work for 300 years maybe you'll see one yourself. Here the picture:
Allopurinol and Progression of Diabetic Kidney Disease. Uric acid is elevated in diabetic kidney disease ,but lowering it with allopurinol does not slow the GFR decline in type 1 diabetes.
Finally, New Onset Diabetes in Covid, a letter about new cases of diabetes as well as exacerbation of previous ones in active COVID infection. They speculate on possible causes for that and announce a registry program colled covidiab.e-dendrite.com.
That is all I found, not a lot really, but we're in summer after all, and obviously covid grabs all the attention.
See you,
